KYMPRAME
Live / Registered — Registered (as of 31 Dec 2024)
What this means for you
Registered since 31 Dec 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97435341
- Registration number
- 7629250
- Mark type
- Stylized text
- Filed
- 31 May 2022
- Published for opposition
- 12 Nov 2024
- Registered
- 31 Dec 2024
- Attorney of record
- Andrew D. Price
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, biological preparations and bispecific reagents for the treatment of tumorous diseases; pharmaceutical preparations, biological preparations and bispecific reagents for the treatment of cancer; pharmaceutical preparations, biological preparations and bispecific reagents for the treatment of melanoma, lung cancer, ovarian cancer, uterine cancer, breast cancer, neurothelial cancer, endometrial cancer, oesophageal cancer, sarcoma, haematological cancers, acute myeloid leukemia, chronic myeloid leukemia, Hodgkin's lymphoma, and head and neck cancers
Owner
- Immunocore Limited, Abingdon, Oxfordshire, GB
- Immunocore Limited, Abingdon, Oxfordshire, GB
- Immunocore Limited, Abingdon, Oxfordshire, GB
Prosecution history
- 31 Dec 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 31 Dec 2024 — REGISTERED-PRINCIPAL REGISTER
- 20 Nov 2024 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 12 Nov 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 12 Nov 2024 — PUBLISHED FOR OPPOSITION
- 23 Oct 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 29 Nov 2023 — ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
- 16 Nov 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 14 Nov 2023 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 14 Nov 2023 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 14 Nov 2023 — ASSIGNED TO LIE
- 09 Jun 2023 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 23 Mar 2023 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 23 Mar 2023 — NON-FINAL ACTION E-MAILED
- 23 Mar 2023 — NON-FINAL ACTION WRITTEN